INNOVATIVE APPROACHES IN CARDIOVASCULAR DISEASE

ARTICLES OF ASSOCIATION
FOR
SERODUS ASA (992 249 897)
(lates amendments made 24 February 2011)
Article 1
The name of the company is Serodus ASA. The company is a public limited company.
Article 2
The company's registered office is located in the municipality of Oslo.
Article 3
The objects of the company include development, production and sale of bio-medical and pharmaceutical products as well as related activities, including participation in and cooperation with other companies.
Article 4
The share capital of the company is NOK 3,605,777.5 divided into 27,736,750 shares, each with a nominal value of NOK 0.13.
Article 5
The board of directors of the company shall consist of 3-7 members. The chairman of the board is elected by the general meeting. The authority to sign on behalf of the company is held by two board members jointly.
Article 6
The company's shares shall be registered with the Norwegian Central Securities Depository, VPS.
Article 7
The ordinary general meeting shall discuss and decide upon the following matters:
- Approval of the annual accounts and annual report, including distribution of dividend
- Any other business that, by law or pursuant to the articles of association, is to be determined by the general meeting.

